Jin C - Search Results

1

Effects of Neoadjuvant Chemotherapy in Ovarian Cancer Patients With Different Germline BRCA1/2 Mutational Status: A Retrospective Cohort Study.

Fu M, Jin C, Feng S, Jia Z, Nie L, Zhang Y, Peng J, Wang X, Bu H, Kong B. Fu M, et al. Among authors: jin c. Front Oncol. 2022 Jan 6;11:810099. doi: 10.3389/fonc.2021.810099. eCollection 2021. Front Oncol. 2022. PMID: 35071013 Free PMC article.

2

Coexistence of benign struma ovarii, pseudo-Meigs' syndrome and elevated serum CA 125: Case report and review of the literature.

Jin C, Dong R, Bu H, Yuan M, Zhang Y, Kong B. Jin C, et al. Oncol Lett. 2015 Apr;9(4):1739-1742. doi: 10.3892/ol.2015.2927. Epub 2015 Feb 3. Oncol Lett. 2015. PMID: 25789033 Free PMC article.

3

Cellular leiomyoma with necrosis and mucinous degeneration presenting as pseudo-Meigs' syndrome with elevated CA125.

Dong R, Jin C, Zhang Q, Yang X, Kong B. Dong R, et al. Among authors: jin c. Oncol Rep. 2015 Jun;33(6):3033-7. doi: 10.3892/or.2015.3912. Epub 2015 Apr 16. Oncol Rep. 2015. PMID: 25891047

4

Spliceosome-associated factor CTNNBL1 promotes proliferation and invasion in ovarian cancer.

Li Y, Guo H, Jin C, Qiu C, Gao M, Zhang L, Liu Z, Kong B. Li Y, et al. Among authors: jin c. Exp Cell Res. 2017 Aug 1;357(1):124-134. doi: 10.1016/j.yexcr.2017.05.008. Epub 2017 May 10. Exp Cell Res. 2017. PMID: 28501461

5

Overexpression of CD47 predicts poor prognosis and promotes cancer cell invasion in high-grade serous ovarian carcinoma.

Li Y, Lu S, Xu Y, Qiu C, Jin C, Wang Y, Liu Z, Kong B. Li Y, et al. Among authors: jin c. Am J Transl Res. 2017 Jun 15;9(6):2901-2910. eCollection 2017. Am J Transl Res. 2017. PMID: 28670378 Free PMC article.

6

A 2-Protein Signature Predicting Clinical Outcome in High-Grade Serous Ovarian Cancer.

Jin C, Xue Y, Li Y, Bu H, Yu H, Zhang T, Zhang Z, Yan S, Lu N, Kong B. Jin C, et al. Int J Gynecol Cancer. 2018 Jan;28(1):51-58. doi: 10.1097/IGC.0000000000001141. Int J Gynecol Cancer. 2018. PMID: 28976449

7

SUSD2 promotes cancer metastasis and confers cisplatin resistance in high grade serous ovarian cancer.

Xu Y, Miao C, Jin C, Qiu C, Li Y, Sun X, Gao M, Lu N, Kong B. Xu Y, et al. Among authors: jin c. Exp Cell Res. 2018 Feb 15;363(2):160-170. doi: 10.1016/j.yexcr.2017.12.029. Epub 2018 Jan 2. Exp Cell Res. 2018. PMID: 29305171

8

FOXD1 is targeted by miR-30a-5p and miR-200a-5p and suppresses the proliferation of human ovarian carcinoma cells by promoting p21 expression in a p53-independent manner.

Wang Y, Qiu C, Lu N, Liu Z, Jin C, Sun C, Bu H, Yu H, Dongol S, Kong B. Wang Y, et al. Among authors: jin c. Int J Oncol. 2018 Jun;52(6):2130-2142. doi: 10.3892/ijo.2018.4359. Epub 2018 Apr 4. Int J Oncol. 2018. PMID: 29620165

9

Combination of TP53 and AGR3 to distinguish ovarian high-grade serous carcinoma from low-grade serous carcinoma.

Qiu C, Wang Y, Wang X, Zhang Q, Li Y, Xu Y, Jin C, Bu H, Zheng W, Yang X, Lu N, Kong B. Qiu C, et al. Among authors: jin c. Int J Oncol. 2018 Jun;52(6):2041-2050. doi: 10.3892/ijo.2018.4360. Epub 2018 Apr 4. Int J Oncol. 2018. PMID: 29620196

10

PCNA-associated factor P15^PAF , targeted by FOXM1, predicts poor prognosis in high-grade serous ovarian cancer patients.

Jin C, Liu Z, Li Y, Bu H, Wang Y, Xu Y, Qiu C, Yan S, Yuan C, Li R, Diao N, Zhang Z, Wang X, Liu L, Kong B. Jin C, et al. Int J Cancer. 2018 Dec 1;143(11):2973-2984. doi: 10.1002/ijc.31800. Epub 2018 Oct 4. Int J Cancer. 2018. PMID: 30129654

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,571 results

Search Page

Filters